Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -4.32 | 11.86 |
| PEG Ratio (TTM) | 0.59 | 1.25 |
| P/S Ratio (TTM) | 1.00 | 4.71 |
| P/B Ratio (TTM) | 0.62 | 3.38 |
| P/FCF Ratio (TTM) | N/A | 21.41 |
| Price to 5YR AVG Earnings Ratio | -4.51 | 30.10 |
| Price to 5YR AVG FCF Ratio | -11.82 | 17.44 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.86% | 3.00% |
| ROE (TTM) | -14.34% | 9.11% |
| Net Profit Margin (TTM) | -24.07% | -15.16% |
| ROIC 5YR AVG | -2.19% | 7.27% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -169.96% | -267.34% | -104.13% |
| Revenue | -10.68% | 288.80% | 186.96% |
| Net Income | -171.12% | -302.03% | -126.01% |
| Cash Flow | -25.00% | 115.01% | 49.07% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 2.54 |
| Quick Ratio (TTM) | 1.17 | 1.92 |
| D/E Ratio (TTM) | 0.29 | -0.26 |
| Interest Coverage (TTM) | N/A | 14.05 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.13 | 4.92 |
| LTL to 5YR AVG FCF | -16.70 | 4.30 |
| Shares Outstanding Growth 5YR AVG | 20.79% | 29.64% |